Tag: DreamStation
Philips Respironics provides testing update
December 27, 2021HME News Staff
AMSTERDAM – Philips Respironics has determined that exposure to the level of VOCs identified to date for the first-generation DreamStation devices is not typically anticipated to result in long-term health consequences for patients.
The announcement comes after an assessment by an outside medical panel and Philips and is intended to give healthcare providers the most recent data. Overall guidance for physicians and patients in the recall notification remains unchanged.
At...
Philips updates providers on FDA report
November 30, 2021HME News Staff
AMSTERDAM, the Netherlands – Philips does not anticipate a delay to its recall or replacement program as a result of a recent report from the U.S. Food and Drug Administration, the company told its provider customers in a Nov. 23 letter.
The FDA recently published the results of its inspection of Philips’ manufacturing facility, noting the silicone-based foam used in a singular, similar CPAP/BiPAP device marketed outside of the U.S. failed one safety test for the release of volatile...
Philips begins remediation
September 1, 2021HME News Staff
AMSTERDAM, the Netherlands – Royal Philips has received authorization from the U.S. Food and Drug Administration to begin replacing the sound abatement foam with new material in certain sleep and respiratory care devices starting this month.
The company has also started replacing certain affected first-generation DreamStation CPAP devices in the U.S. with DreamStation 2 CPAP devices, which aren’t affected by the recall.
“We fully recognize...
Philips recall: Senator pushes for answers
August 30, 2021HME News Staff
WASHINGTON – Sen. Richard Blumenthal, D-Conn., sent a three-page letter to Vitor Rocha, the CEO of Philips North America, on Aug. 24, asking him to answer seven questions, including, when does Philips expect to have repaired or replaced all impacted devices?
Blumenthal writes that he has heard from constituents with concerns about the lack of information surrounding a recall of certain Philips CPAP devices and ventilators announced in June.
“The current situation is...
Providers assess Philips recall
June 18, 2021Theresa Flaherty, Managing Editor
YARMOUTH, Maine – HME providers had far more questions than answers as they scrambled to field patient inquiries and craft game plans in the days following the news of a voluntary recall of Philips’ first generation DreamStation CPAP devices.
Philips announced the recall on June 14 to address identified potential health risks related to the polyester-based polyurethane sound abatement foam component in certain Bi-Level, CPAP and mechanical ventilator devices.
“We’re...
Makers of CPAP cleaners distance themselves from recall
June 18, 2021Liz Beaulieu, Editor
PETERSBOROUGH, N.H. – SoClean is standing by its CPAP cleaning device, after Philips said “unapproved cleaning methods, such as ozone,” may be exacerbating the degradation of sound abatement foam in its first-generation DreamStation product family.
Philips made the claim as part of a voluntary recall announced June 14 to address identified potential health risks related to the polyester-based polyurethane foam in certain Bi-Level CPAP, CPAP and mechanical ventilator...
Philips issues recall
June 14, 2021HME News Staff
AMSTERDAM – Royal Philips has announced, in consultation with regulatory agencies, a voluntary recall notification on certain Bi-Level CPAP, CPAP and mechanical ventilator devices to address identified potential health risks related to the polyester-based polyurethane sound abatement foam component in these devices.
The majority of affected devices within the advised five-year service life are in the first-generation DreamStation product family, the company says.
“We...
Philips gets in front of possible safety issue
April 30, 2021Liz Beaulieu, Editor
CAMBRIDGE, Mass. – There’s only a “small risk” that the sound abatement foam in the first-generation DreamStation is being compromised by outside factors, including ozone cleaners, but Philips has chosen to be proactive and fix or replace these CPAP devices in the U.S., says CEO Frans van Houten.
The occurrence rate of deterioration of the foam is about 0.03%, based on internal user reports and testing, the company says.
“The use of ozone is typically a U.S....
Philips reports possible safety issue
April 27, 2021HME News Staff
CAMBRIDGE, Mass. – Philips has determined from user reports and testing that there are possible risks to users related to the sound abatement foam used in certain of the company’s sleep and respiratory care devices.
“The risks include that the foam may degrade under certain circumstances, influenced by factors including use of unapproved cleaning methods, such as ozone, and certain environmental conditions involving high humidity and temperature,” the company stated...